Drug profile · INN
sutimlimab
ENJAYMO
- Patents linked
- 0
- News articles
- 0
Quick answer
sutimlimab (ENJAYMO) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN sutimlimab
Brand ENJAYMO
ATC code L04AJ04
Frequently asked questions
What is sutimlimab?
sutimlimab (ENJAYMO) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for sutimlimab?
ENJAYMO is a marketed brand name for sutimlimab. Check FDA Drugs@FDA for the current US label holder and prescribing information.